Nexus of Pathophysiology and Therapeutics (NPT) is an international, peer-reviewed, open-access journal dedicated to advancing the mechanistic understanding of disease biology and translating these insights into therapeutic innovations that improve patient care and clinical outcomes.
The journal provides a high-impact, cross-disciplinary platform for research spanning molecular and cellular biology, pharmacology, experimental medicine, computational science, and clinical investigation. NPT actively fosters interdisciplinary approaches that bridge fundamental laboratory discovery with applied therapeutic development, placing a powerful emphasis on translational relevance and real-world clinical impact.
NPT prioritizes well-designed studies and clinical analyses that successfully:
Elucidate Mechanistic Pathways: Uncover the precise molecular, cellular, and tissue-level signaling networks underlying disease initiation and progression.
Investigate Comprehensive Therapeutic Actions: Evaluate drug actions, pharmacodynamics, and target engagements across biological scales (from single receptors to complex systems biology).
Translate Fundamental Discoveries: Convert basic mechanistic findings into clinically actionable insights, innovative biomarkers, and targeted therapeutic strategies.
Rigorous Evaluation: All manuscripts undergo strict double-blind peer review to guarantee scientific integrity, methodological rigor, and mechanistic validity.
Ethical Governance: The journal adheres to the highest benchmarks of publication ethics, fully complying with the internationally recognized guidelines of the Committee on Publication Ethics (COPE) and the International Committee of Medical Journal Editors (ICMJE).
Continuous Publication Model: To facilitate rapid scientific exchange, NPT operates under a continuous publication workflow. Accepted articles are instantly technical-typeset, assigned a permanent DOI, and published online, ensuring immediate global dissemination without publication delays.
Operating under the Creative Commons Attribution 4.0 International (CC BY 4.0) license, NPT provides unrestricted, immediate open access to all published literature. Anyone worldwide is free to read, download, distribute, and build upon the work, provided the original authors and the journal are appropriately cited.
NPT proudly welcomes contributions from an international community of researchers, molecular pharmacologists, translational scientists, and clinicians. By providing a trusted, high-standard platform, the journal aims to accelerate the translation of scientific discovery into next-generation therapeutic strategies—ultimately shaping the future of precision medicine and improved patient care.
